- Report
- April 2023
- 600 Pages
Global
From €5801EUR$6,000USD£4,983GBP
- Report
- February 2023
- 137 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- November 2022
- 296 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- March 2022
- 128 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- May 2020
- 125 Pages
Global
From €3867EUR$4,000USD£3,322GBP
- Report
- April 2020
- 105 Pages
Global
From €725EUR$750USD£623GBP
- Report
- February 2019
- 183 Pages
United States
From €4109EUR$4,250USD£3,529GBP
- Report
- September 2021
- 90 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- January 2023
- 180 Pages
North America
From €5752EUR$5,950USD£4,941GBP
- Report
- January 2023
- 110 Pages
Global
From €5752EUR$5,950USD£4,941GBP
- Report
- January 2019
- 293 Pages
Global
From €4036EUR$4,175USD£3,467GBP
- Report
- July 2021
- 193 Pages
India
From €3045EUR$3,150USD£2,616GBP
- Report
- April 2024
- 136 Pages
Global
From €3770EUR$3,899USD£3,238GBP
- Report
- January 2022
- 160 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- September 2022
- 135 Pages
United States
From €2891EUR$2,990USD£2,483GBP
- Report
- October 2023
- 70 Pages
India
From €3384EUR$3,500USD£2,906GBP
- Report
- July 2022
- 45 Pages
United States
From €4786EUR$4,950USD£4,111GBP
- Report
- October 2018
- 56 Pages
United States
From €1450EUR$1,500USD£1,246GBP
- Report
- March 2023
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
- Report
- July 2022
- 100 Pages
Global
From €2659EUR$2,750USD£2,284GBP
Point-of-Care (POC) Molecular Diagnostics is a rapidly growing field of medical diagnostics that enables the detection of genetic material from a patient sample at the point of care. This technology is used to detect and diagnose a wide range of diseases, including infectious diseases, cancer, and genetic disorders. POC Molecular Diagnostics offers a number of advantages over traditional laboratory-based testing, including faster turnaround times, improved accuracy, and cost savings.
POC Molecular Diagnostics is used in a variety of settings, including hospitals, clinics, and laboratories. It is also increasingly being used in home settings, allowing patients to self-test for a variety of conditions. This technology is also being used in the field of public health, allowing for rapid detection and response to outbreaks of infectious diseases.
Some companies in the POC Molecular Diagnostics market include Cepheid, Hologic, Abbott, and Roche. Show Less Read more
